The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality
Launched by KAROLINSKA INSTITUTET · May 14, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of bariatric surgery, a weight-loss surgery, on heart disease and death rates in people with obesity. The researchers want to find out if this surgery helps reduce the risk of heart problems and death, and if one type of surgery works better than another. They will look at data from individuals in Sweden who are eligible for bariatric surgery, comparing health outcomes for those who have the surgery with those who are managing their weight without surgery.
To be eligible for this trial, participants must be men or women of reproductive age who have been diagnosed with obesity but do not have a history of heart disease or cancer. They also should not have any medical reasons that would prevent them from having surgery. If you join the trial, you can expect to be part of a study that aims to better understand how weight-loss surgery affects heart health and how different types of surgery may be more effective for certain individuals. This research could help many people make informed decisions about their health and treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women of reproductive age with a diagnosis of obesity, no prior history of cardiovascular disease or cancer, and no contraindications for surgery after 1982
- Exclusion Criteria:
- • Contraindications to bariatric surgery
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0